Efficacy News and Research

RSS
Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

Multicenter study determines the efficacy of SARS-CoV-2 vaccination against Post-Acute Sequelae of COVID-19

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Study explores macromolecular viral entry inhibitors as broad-spectrum first-line antivirals with anti-SARS-CoV-2 activities

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Investigating effectiveness of mRNA booster against SARS-CoV-2 Omicron in individuals primed with mRNA or inactivated virus vaccines

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

Exploring short-term effectiveness of COVID-19 booster vaccine and stable CD8+ T cell memory after three doses

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

SARS-CoV-2 N-terminal domain modulates S1/S2 cleavage and spike-mediated functions

Topical drugs may regress congenital giant nevi and prevent skin cancer

Topical drugs may regress congenital giant nevi and prevent skin cancer

Penn study finds low uptake of first mutation-targeted bladder cancer drug

Penn study finds low uptake of first mutation-targeted bladder cancer drug

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Cost-effective ovine antibody-based therapy against SARS-CoV-2 infection

Study could provide a new approach to treating metastatic triple negative breast cancer

Study could provide a new approach to treating metastatic triple negative breast cancer

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Phase 1 trial of COVID-19 PTXCOVID19-B vaccine

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

Study finds recent influenza vaccination is associated with an appreciable reduction in the risk of SARS-CoV-2 infection and COVID-19 severity

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

COVID-19 booster vaccination strategy found to be highly cost-effective in Australia

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Study projects the COVID-19 burden caused by Omicron infections in mainland China should the zero-COVID policy be lifted

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Research looks at potential of pantethine against SARS-CoV-2

Research looks at potential of pantethine against SARS-CoV-2

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Study estimates effectiveness of 2-dose and 3-dose mRNA vaccination against Omicron

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

Antifungal agent Bifonazole as an antiviral against SARS-CoV-2

The promise of RNA medicine is targeted and personalized

The promise of RNA medicine is targeted and personalized

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

Clemson researchers discover a promising therapy for people suffering from toxoplasmosis

First oral antiviral approved for early treatment of COVID-19

First oral antiviral approved for early treatment of COVID-19

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.